Janssen-Ortho Inc. et al. v. Novopharm Ltd. et al., (2005) 337 N.R. 259 (FCA)
Linked as:
Extract
Janssen-Ortho Inc. et al. v. Novopharm Ltd. et al., (2005) 337 N.R. 259 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Janssen-Ortho Inc. et al. v. Novopharm Ltd. et al., (2004) 264 F.T.R. 202 (FC)
- Novartis AG et al. v. Apotex Inc. et al., (2002) 298 N.R. 348 (FCA)
- Merck Frosst Canada Inc. et al. v. Apotex Inc. et al., (1999) 240 N.R. 195 (FCA)
- AstraZeneca AB et al. v. Apotex Inc. et al., 2004 FCA 224
- Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2001) 266 N.R. 371 (FCA)
